Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Artificial insemination for giant panda
High hopes after Edinburgh Zoo performs procedure

The UK's first ever artificial insemination on a giant panda has been carried out at the Royal Zoological Society of Scotland's (RZSS) Edinburgh Zoo.

Tian Tian, the female giant panda,
had a 36-hour window to breed after she ovulated on Saturday, April 20. However, she and her partner Yang Guang were not able to mate.

It was decided that artificial insemination would be the best step to take, following advice given by Chinese panda mating expert, Professor Wang, of the China Conservation and Research Centre.

Early on Sunday, April 21, Tian Tian's uterus was injected with semen, as part of the overall global panda conservation effort.

A team of world experts in artificial insemination and reproduction management helped the RZSS veterinary surgeons, scientific and animal staff perform the procedure.

To prevent anaphylactic shock, thawed semen must be used first. Since there was not enough frozen semen belonging to Yang Guang, a sample belonging to Berlin Zoo's Bao Bao was also used.

Iain Valentine, RZSS's director of giant pandas, said: "It would have been amazing if the pandas had mated naturally, however, artificial insemination is the next best thing for the overall global conservation effort and the individual biology of Tian Tian, our female.

"With every year that goes by where she does not become pregnant, it becomes harder for her to become pregnant naturally."

Valentine added that both pandas are doing well and that the procedure went to plan.

It will not be known whether the insemination has been a success until late July to early August.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.